Summary of Purpose
To assess the safety, tolerability, and pharmacokinetics of loading and maintenance infusions of GV150526 in patients with acute stroke.Read More →
The following dates are available for this trial. Trial information last updated on 19 July 2001.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Glaxo Wellcome, Research Triangle, NC
Randomized, placebo-controlled, parallel-group, ascending-dose study conducted in 2 phases. In part A of the study, loading doses of 50, 100, 200, 400, or 800 mg were administered. In part B, the maximum loading dose from part A was followed by maintenance infusions (5 infusions at 12-hour intervals), aiming to maintain neuroprotective levels. The trial included 66 patients.
Dr A.G. Dyker, University Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, Scotland.firstname.lastname@example.org